Get early access! Join the Twelve Data AI Assistant waitlist now.
7.79400 EUR
0.514
7.06%
Last update Sep 4, 8:06 PM CEST
Main market
Day range
7.79200
7.79600
Previous close
7.28000
Open
7.79200
Access this stock data via API
Subscribe
Innocan Pharma Corporation
7.79
0.51
7.06%

Statistics

Valuation metrics
Market cap
38.88M
Enterprise value
23.36M
Trailing P/E (ttm)
-779.40
Forward P/E
PEG ratio
2.60
Price/Sales (ttm)
0.02
Price/Book (mrq)
0.12
Enterprise Value/Revenue
0.95
Enterprise Value/EBITDA
77.83
Overview
Shares outstanding
247.41M
Float
4.48M
Shares short
% Held by insiders
% Held by institutions
Average volume (10 days)
4.91K
Average volume (90 days)
5.70K
Price summary
52-Week low
0.10
52-Week high
9.10
52-Week change
98.14 101,175.3%
Beta
-0.43
50-Day moving average
0.94
200-Day moving average
0.32
Financials
Fiscal year
Fiscal year ends
Dec 31, 2024
Most recent quarter (mrq)
Jun 30, 2025
Profitability
Profit margin
-5.47%
Operating margin
5.65%
Operational effectiveness
Return on assets
2.01%
Return on equity
-4.84%
Income statement
Revenue (ttm)
24.58M
Revenue per share (ttm)
6.51
Quarterly revenue growth (yoy)
-19%
Gross profit (ttm)
21.74M
EBITDA
300.19K
Net income to common (ttm)
-1.34M
Diluted EPS (ttm)
-0.50
Quarterly earnings growth (yoy)
-19.39%
Balance sheet
Total cash (mrq)
6.19M
Total cash per share (mrq)
1.61
Total debt (mrq)
1.19M
Total Debt/Equity (mrq)
20.89
Current ratio (mrq)
370.20%
Book value per share (mrq)
0.94
Cash flow
Cash flow statement
-386.32K
Levered free cash flow (LFCF)
695.25K
Main market

Exchange is currently active.
Closing in 10 hours 42 minutes

11:17
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CEST, UTC+02:00).